-Search query
-Search result
Showing 1 - 50 of 52 items for (author: burrell & a)
EMDB-41986:
Human retinal variant phosphomimetic IMPDH1(595)-S477D free octamer bound by GTP, ATP, IMP, and NAD+
Method: single particle / : Calise SJ, Kollman JM
EMDB-41989:
Human retinal variant phosphomimetic IMPDH1(546)-S477D filament bound by GTP, ATP, IMP, and NAD+, octamer-centered
Method: single particle / : Calise SJ, Kollman JM
EMDB-42012:
Human retinal variant phosphomimetic IMPDH1(546)-S477D filament bound by GTP, ATP, IMP, and NAD+, interface-centered
Method: single particle / : Calise SJ, Kollman JM
EMDB-42026:
Human retinal variant phosphomimetic IMPDH1(546)-S477D filament bound by ATP, IMP, and NAD+, octamer-centered
Method: single particle / : Calise SJ, Kollman JM
EMDB-42029:
Human retinal variant phosphomimetic IMPDH1(546)-S477D filament bound by ATP, IMP, and NAD+, interface-centered
Method: single particle / : Calise SJ, Kollman JM
PDB-8u7m:
Human retinal variant phosphomimetic IMPDH1(595)-S477D free octamer bound by GTP, ATP, IMP, and NAD+
Method: single particle / : Calise SJ, Kollman JM
PDB-8u7q:
Human retinal variant phosphomimetic IMPDH1(546)-S477D filament bound by GTP, ATP, IMP, and NAD+, octamer-centered
Method: single particle / : Calise SJ, Kollman JM
PDB-8u7v:
Human retinal variant phosphomimetic IMPDH1(546)-S477D filament bound by GTP, ATP, IMP, and NAD+, interface-centered
Method: single particle / : Calise SJ, Kollman JM
PDB-8u8o:
Human retinal variant phosphomimetic IMPDH1(546)-S477D filament bound by ATP, IMP, and NAD+, octamer-centered
Method: single particle / : Calise SJ, Kollman JM
PDB-8u8y:
Human retinal variant phosphomimetic IMPDH1(546)-S477D filament bound by ATP, IMP, and NAD+, interface-centered
Method: single particle / : Calise SJ, Kollman JM
EMDB-29357:
Human IMPDH2 mutant - L245P, treated with ATP, IMP, and NAD+; filament assembly interface reconstruction
Method: single particle / : O'Neill AG, Kollman JM
EMDB-29482:
Human IMPDH2 mutant - L245P, treated with GTP, ATP, IMP, and NAD+; filament assembly interface reconstruction
Method: single particle / : O'Neill AG, Kollman JM
EMDB-29848:
Human IMPDH2 mutant - L245P, treated with ATP, IMP, and NAD+; extended filament segment reconstruction
Method: single particle / : O'Neill AG, Kollman JM
EMDB-29863:
Human IMPDH2 mutant - L245P, treated with GTP, ATP, IMP, and NAD+; compressed filament segment reconstruction
Method: single particle / : O'Neill AG, Kollman JM
EMDB-29870:
Human IMPDH2 mutant - L245P, treated with GTP, ATP, IMP, and NAD+; bent filament segment reconstruction
Method: single particle / : O'Neill AG, Kollman JM
PDB-8foz:
Human IMPDH2 mutant - L245P, treated with ATP, IMP, and NAD+; filament assembly interface reconstruction
Method: single particle / : O'Neill AG, Kollman JM
PDB-8fuz:
Human IMPDH2 mutant - L245P, treated with GTP, ATP, IMP, and NAD+; filament assembly interface reconstruction
Method: single particle / : O'Neill AG, Kollman JM
PDB-8g8f:
Human IMPDH2 mutant - L245P, treated with ATP, IMP, and NAD+; extended filament segment reconstruction
Method: single particle / : O'Neill AG, Kollman JM
PDB-8g9b:
Human IMPDH2 mutant - L245P, treated with GTP, ATP, IMP, and NAD+; compressed filament segment reconstruction
Method: single particle / : O'Neill AG, Kollman JM
EMDB-24437:
HUMAN IMPDH1 TREATED WITH ATP, IMP, AND NAD+
Method: single particle / : Burrell AL, Kollman JM
EMDB-24438:
HUMAN IMPDH1 TREATED WITH ATP, IMP, AND NAD+; OCTAMER-CENTERED
Method: single particle / : Burrell AL, Kollman JM
EMDB-24439:
HUMAN IMPDH1 TREATED WITH GTP, IMP, AND NAD+; INTERFACE-CENTERED
Method: single particle / : Burrell AL, Kollman JM
EMDB-24440:
HUMAN RETINAL VARIANT IMPDH1(595) TREATED WITH ATP; INTERFACE-CENTERED
Method: single particle / : Burrell AL, Kollman JM
EMDB-24441:
HUMAN IMPDH1 TREATED WITH GTP, IMP, AND NAD+ OCTAMER-CENTERED
Method: single particle / : Burrell AL, Kollman JM
EMDB-24442:
HUMAN RETINAL VARIANT IMPDH1(595) TREATED WITH ATP, OCTAMER-CENTERED
Method: single particle / : Burrell AL, Kollman JM
EMDB-24443:
HUMAN RETINAL VARIANT IMPDH1(595) TREATED WITH GTP, ATP, IMP, NAD+, INTERFACE-CENTERED
Method: single particle / : Burrell AL, Kollman JM
EMDB-24448:
HUMAN RETINAL VARIANT IMPDH1(595) TREATED WITH GTP, ATP, IMP, NAD+, OCTAMER-CENTERED
Method: single particle / : Burrell AL, Kollman JM
EMDB-24450:
HUMAN RETINAL VARIANT IMPDH1(546) TREATED WITH GTP, ATP, IMP, NAD+; INTERFACE-CENTERED
Method: single particle / : Burrell AL, Kollman JM
EMDB-24451:
HUMAN RETINAL VARIANT IMPDH1(546) TREATED WITH ATP, IMP, NAD+, INTERFACE-CENTERED
Method: single particle / : Burrell AL, Kollman JM
EMDB-24452:
HUMAN RETINAL VARIANT IMPDH1(546) TREATED WITH ATP, IMP, NAD+, OCTAMER-CENTERED
Method: single particle / : Burrell AL, Kollman JM
EMDB-24454:
HUMAN RETINAL VARIANT IMPDH1(546) TREATED WITH GTP, ATP, IMP, NAD+; INTERFACE-CENTERED
Method: single particle / : Burrell AL, Kollman JM
PDB-7rer:
HUMAN IMPDH1 TREATED WITH ATP, IMP, AND NAD+
Method: single particle / : Burrell AL, Kollman JM
PDB-7res:
HUMAN IMPDH1 TREATED WITH ATP, IMP, AND NAD+, OCTAMER-CENTERED
Method: single particle / : Burrell AL, Kollman JM
PDB-7rfe:
HUMAN IMPDH1 TREATED WITH GTP, IMP, AND NAD+; INTERFACE-CENTERED
Method: single particle / : Burrell AL, Kollman JM
PDB-7rff:
HUMAN RETINAL VARIANT IMPDH1(595) TREATED WITH ATP; INTERFACE-CENTERED
Method: single particle / : Burrell AL, Kollman JM
PDB-7rfg:
HUMAN IMPDH1 TREATED WITH GTP, IMP, AND NAD+ OCTAMER-CENTERED
Method: single particle / : Burrell AL, Kollman JM
PDB-7rfh:
HUMAN RETINAL VARIANT IMPDH1(595) TREATED WITH ATP, OCTAMER-CENTERED
Method: single particle / : Burrell AL, Kollman JM
PDB-7rfi:
HUMAN RETINAL VARIANT IMPDH1(595) TREATED WITH GTP, ATP, IMP, NAD+, INTERFACE-CENTERED
Method: single particle / : Burrell AL, Kollman JM
PDB-7rgd:
HUMAN RETINAL VARIANT IMPDH1(595) TREATED WITH GTP, ATP, IMP, NAD+, OCTAMER-CENTERED
Method: single particle / : Burrell AL, Kollman JM
PDB-7rgi:
HUMAN RETINAL VARIANT IMPDH1(546) TREATED WITH GTP, ATP, IMP, NAD+; INTERFACE-CENTERED
Method: single particle / : Burrell AL, Kollman JM
PDB-7rgl:
HUMAN RETINAL VARIANT IMPDH1(546) TREATED WITH ATP, IMP, NAD+, INTERFACE-CENTERED
Method: single particle / : Burrell AL, Kollman JM
PDB-7rgm:
HUMAN RETINAL VARIANT IMPDH1(546) TREATED WITH ATP, IMP, NAD+, OCTAMER-CENTERED
Method: single particle / : Burrell AL, Kollman JM
PDB-7rgq:
HUMAN RETINAL VARIANT IMPDH1(546) TREATED WITH GTP, ATP, IMP, NAD+; INTERFACE-CENTERED
Method: single particle / : Burrell AL, Kollman JM
EMDB-22581:
Cryo-EM structure of the BRCA1-UbcH5c/BARD1 E3-E2 module bound to a nucleosome
Method: single particle / : Witus SR, Burrell AL, Hansen JM, Farrell DP, Dimaio F, Kollman JM, Klevit RE
PDB-7jzv:
Cryo-EM structure of the BRCA1-UbcH5c/BARD1 E3-E2 module bound to a nucleosome
Method: single particle / : Witus SR, Burrell AL, Hansen JM, Farrell DP, Dimaio F, Kollman JM, Klevit RE
EMDB-0007:
MlaBDEF complex from A. baumannii
Method: single particle / : Bergeron JRC, Kollman JM
PDB-6ic4:
Cryo-EM structure of the A. baumannii MLA complex at 8.7 A resolution
Method: single particle / : Bergeron JR, Kollman JM
EMDB-8690:
IMPDH Filament in the GTP-bound collapsed conformation
Method: helical / : Kollman JM, Burrell AL, Johnson MC
EMDB-8691:
IMPDH Filament in the expanded conformation
Method: helical / : Kollman JM, Burrell AL, Johnson MC
EMDB-8692:
Human Inosine Monophosphate Dehydrogenase 2 (hIMPDH2), Y12A mutant
Method: single particle / : Kollman JK, Johnson MC, Burrell AL
Pages: